ArticleMagma (New York, N.Y.)2025
Diffusion-weighted magnetic resonance spectroscopy with selective refocusing.
Article in Magma (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo reduce errors from J-modulations and spectral overlap in dMRS of brain metabolites, this study combines the use of diffusion-weighted gradients with selective refocusing and spectral editing. MATERIALS AND
methodsBipolar gradients were combined with spectral refocusing and editing in a dMEGA-PRESS sequence. Experimental parameters were optimised for spectral editing of GABA, with co-editing of Glutamate and Glutamine. The method was tested in metabolite phantom solutions, followed by pre-clinical experiments on rats.
resultsThe dMEGA-PRESS sequence enabled reliable spectral editing and quantification of GABA. Selective refocusing and editing resulted in reduced uncertainty in the diffusion data for GABA and Glutamate in the metabolite phantoms, and also for the combined Glutamate/Glutamine diffusion data obtained in vivo. Reliable diffusion data for GABA was not possible to obtain from the in vivo spectra. DISCUSSION: For metabolites with significant J-modulations but without spectral overlap, selective refocusing improved the quality of diffusion data. For metabolites with spectral overlap where editing is necessary, spectral subtraction makes it more challenging to improve the quality of diffusion-weighted data.
conclusionThe dMEGA-PRESS sequence reduces the uncertainty in obtained diffusion data for brain metabolites that are significantly influenced by J-modulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.